Immunogenicity of a bivalent Omicron BA.1 COVID-19 booster vaccination in people with HIV in the Netherlands

被引：0
|
作者：
Jongkees, M. J. [1 ,2 ]
Tan, N. H. [3 ]
Geers, D. [4 ]
de Vries, R. D. [4 ]
GeurtsvanKessel, C. H. [4 ]
Hensley, K. S. [1 ,2 ]
Sablerolles, S. G. [3 ]
Bogers, S. [4 ]
Blakaj, B. [5 ]
Afonso, P. Miranda [6 ]
Hansen, B. E. [6 ,7 ,8 ,9 ]
Rijnders, B. J. A. [1 ,2 ]
Brinkman, K. [10 ]
van der Kuy, H. M. [3 ]
Roukens, A. H. E. [11 ]
Rokx, C. [1 ,2 ]
机构：
[1] Erasmus MC, Sect Infect Dis, Dept Internal Med, Rotterdam, Netherlands
[2] Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands
[3] Erasmus MC, Dept Hosp Pharm, Rotterdam, Netherlands
[4] Erasmus MC, Dept Virosci, Rotterdam, Netherlands
[5] Erasmus MC, Dept Med Oncol, Rotterdam, Netherlands
[6] Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands
[7] Univ Toronto, IHPME, Toronto, ON, Canada
[8] Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada
[9] Univ Hlth Network, TGHRI, Toronto, ON, Canada
[10] OLVG Hosp, Dept Internal Med & Infect Dis, Amsterdam, Netherlands
[11] Leiden Univ, Dept Infect Dis, Med Ctr, Rotterdam, Netherlands
来源：
HIV MEDICINE | 2023年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
EACS2023:
引用
收藏
页码：305 / 306
页数：2
相关论文
共 50 条
  • [41] Immune response to mRNA-based COVID-19 booster vaccination in people living with HIV
    Malin, Jakob J.
    Suarez, Isabelle
    Biehl, Lena
    Schommers, Phillip
    Knops, Elena
    Di Cristanziano, Veronica
    Heger, Eva
    Pflieger, Eva
    Wyen, Christoph
    Bettin, Daniel
    Rybniker, Jan
    Faetkenheuer, Gerd
    Lehmann, Clara
    HIV MEDICINE, 2023, 24 : 78 - 79
  • [42] Induction of High Neutralizing Activity Against Both Omicron BA.2 and Omicron BA.1 by Coronavirus Disease 2019 Messenger RNA Booster Vaccination
    Tjan, Lidya Handayani
    Furukawa, Koichi
    Kurahashi, Yukiya
    Sutandhio, Silvia
    Nishimura, Mitsuhiro
    Arii, Jun
    Mori, Yasuko
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (08): : 1481 - 1483
  • [43] Prioritise people with HIV for COVID-19 vaccination
    不详
    LANCET HIV, 2021, 8 (11): : E659 - E659
  • [44] Immune response to mRNA-based COVID-19 booster vaccination in people living with HIV
    Malin, Jakob J.
    Suarez, Isabelle
    Biehl, Lena M.
    Schommers, Philipp
    Knops, Elena
    Di Cristanziano, Veronica
    Heger, Eva
    Pflieger, Eva
    Wyen, Christoph
    Bettin, Daniel
    Rybniker, Jan
    Faetkenheuer, Gerd
    Lehmann, Clara
    HIV MEDICINE, 2023, 24 (07) : 785 - 793
  • [45] Public health impact and economic value of booster vaccination with Pfizer-BioNTech COVID-19 vaccine, bivalent (Original and Omicron BA.4/BA.5) in the United States
    Di Fusco, Manuela
    Marczell, Kinga
    Thoburn, Elizabeth
    Wiemken, Timothy. L. L.
    Yang, Jingyan
    Yarnoff, Benjamin
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 509 - 524
  • [46] Persistence of immunity against Omicron BA.1 and BA.2 variants following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-dose AZD1222 vaccination
    Assawakosri, Suvichada
    Kanokudom, Sitthichai
    Chansaenroj, Jira
    Suntronwong, Nungruthai
    Auphimai, Chompoonut
    Nilyanimit, Pornjarim
    Vichaiwattana, Preeyaporn
    Thongmee, Thanunrat
    Duangchinda, Thaneeya
    Chantima, Warangkana
    Pakchotanon, Pattarakul
    Srimuan, Donchida
    Thatsanatorn, Thaksaporn
    Klinfueng, Sirapa
    Sudhinaraset, Natthinee
    Mongkolsapaya, Juthathip
    Wanlapakorn, Nasamon
    Honsawek, Sittisak
    Poovorawan, Yong
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 122 : 793 - 801
  • [47] Bivalent COVID-19 booster vaccines and the absence of BA.5-specific antibodies
    Carreno, Juan Manuel
    Singh, Gagandeep
    Simon, Viviana
    Krammer, Florian
    LANCET MICROBE, 2023, 4 (08): : E569 - E569
  • [48] Omicron variant and booster COVID-19 vaccines
    Burki, Talha Khan
    LANCET RESPIRATORY MEDICINE, 2022, 10 (02): : E17 - E17
  • [49] Outcomes of pregnant women exposed to Sotrovimab for the treatment of COVID-19 in the BA.1 Omicron predominant era (PRESTO)
    Tuan, Jessica J.
    Sharma, Manas
    Kayani, Jehanzeb
    Davis, Matthew W.
    McManus, Dayna
    Topal, Jeffrey E.
    Ogbuagu, Onyema
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [50] Risk Factors Related to COVID-19 Reinfection and Fatality During the Omicron (BA.1/BA. 2) Period in Korea
    Lee, Ju Hee
    Hwang, Ji Hae
    Jang, Eun Jung
    Kim, Ryu Kyung
    Lee, Kil Hun
    Park, Seon Kyeong
    Gwack, Jin
    Park, Young Joon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (34)
12345